Skip to main content
Premium Trial:

Request an Annual Quote

Agilent to Acquire Silicon Genetics

NEW YORK, Aug. 23 (GenomeWeb News) - Agilent Technologies has signed an agreement to acquire life science software provider Silicon Genetics, the companies said today.

 

"Silicon Genetics brings Agilent an outstanding informatics product portfolio and a strong team of people with extensive experience in software development, marketing, sales and support," Fran DiNuzzo, vice president and general manager of Agilent's Integrated Biology Solutions business, said in a statement. "Our combined organizations will offer customers an unparalleled range of informatics solutions spanning applications in gene expression, genotyping, and protein identification."

 

Silicon Genetics' products include GeneSpring, a genomic expression visualization and analysis platform; Varia, a line of genetic analysis software; and GeNet, a scalable repository for expression data.

 

Financial terms of the proposed acquisition were not disclosed.

 

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.